About
Who We Are
Genentech (GNE), a member of the Roche group and founder of the biotechnology industry, is dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. To solve the world's most complex health challenges, we ask bigger questions that challenge our industry and the boundaries of science to transform society. Our transformational discoveries include the first targeted antibody for cancer and the first medicine...
Updates & Highlights
Bloomberg Law News · 2 days ago
Genentech Brings New Perjeta Infringement Suit Over Biosimilar
The Business Journals · 9 days ago
Genentech's parent company slims obesity lineup from $3 billion East Bay buyout
Pulse 2.0 · 10 days ago
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
Recent Openings
View all 7 jobs arrow_forwardMachine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
All Jobs
Machine Learning Engineer/Senior Machine Learning Engineer - Infra
location_on New York, NY, US
Culture & Mission
Benefits & Perks
Equity/Stock Options
Ownership in the company
Health Insurance
Medical, dental & vision
Learning Budget
Professional development
Generous PTO
Paid time off
Competitive Salary
Market-rate compensation
Remote Work
Work from anywhere flexibility
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Genentech?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company arrow_forwardNews & Press
20 recentGenentech Brings New Perjeta Infringement Suit Over Biosimilar
Genentech Brings New Perjeta Infringement Suit Over Biosimilar
Bloomberg Law News · 2 days ago
Genentech's parent company slims obesity lineup from $3 billion East Bay buyout
Genentech's parent company slims obesity lineup from $3 billion East Bay buyout
The Business Journals · 9 days ago
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
MaxCyte Partners With Genentech To Support Cell Therapy Development And Manufacturing
Pulse 2.0 · 10 days ago
Genentech Increases Lobbying Amid Drug Pricing Pressure
Genentech Increases Lobbying Amid Drug Pricing Pressure
Legis1 · 12 days ago
MaxCyte stock surges on Genentech technology license deal
MaxCyte stock surges on Genentech technology license deal
Investing.com · 12 days ago
MaxCyte Enters Technology License Partnership With Genentech
MaxCyte Enters Technology License Partnership With Genentech
marketscreener.com · 12 days ago
Genentech licenses MaxCyte cell engineering technology
Genentech licenses MaxCyte cell engineering technology
Investing.com · 12 days ago
MaxCyte licenses cell therapy tech to Genentech for research and manufacturing support
MaxCyte licenses cell therapy tech to Genentech for research and manufacturing support
Pluang · 12 days ago
Genentech Gets Access to MaxCyte Cell-Engineering Platforms
Genentech Gets Access to MaxCyte Cell-Engineering Platforms
Stock Titan · 12 days ago
How Genentech Is Shaping Cancer Care: Legacy, Partnerships and Innovation
How Genentech Is Shaping Cancer Care: Legacy, Partnerships and Innovation
Genentech · 14 days ago
Genentech’s Gazyva Receives FDA Priority Review for Primary Membranous Nephropathy
Genentech’s Gazyva Receives FDA Priority Review for Primary Membranous Nephropathy
Yahoo Finance · 18 days ago
FDA grants priority review to Genentech’s Gazyva sBLA in pMN
FDA grants priority review to Genentech’s Gazyva sBLA in pMN
The Pharma Letter · 18 days ago
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
FDA Grants Priority Review to Genentech’s Gazyva for Adults With Primary Membranous Nephropathy
The Norfolk Daily News · 18 days ago
Wei Liu։ Genentech to Lay Off Veteran Scientists
Wei Liu։ Genentech to Lay Off Veteran Scientists
Oncodaily · 26 days ago
Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC
Genentech and Roche Present New Data in Alzheimer’s Disease From Across Its Integrated Pharmaceutical and Diagnostics Portfolio at AAIC
Business Wire · 26 days ago
Astex strikes cancer collaboration with Genentech
Astex strikes cancer collaboration with Genentech
The Pharma Letter · 27 days ago
Genentech signs $490m breast cancer deal with Astex
Genentech signs $490m breast cancer deal with Astex
European Biotechnology Magazine · 27 days ago
Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
Astex Announces Exclusive Research Collaboration and License Agreement with Genentech for Breast Cancer Therapy Program
Yahoo Finance · 27 days ago
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
Genentech culls 103 jobs, inks $490M-plus biobucks deal with Astex
BioSpace · 27 days ago
Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab
Genentech lays off 103 alongside gRED rethink, pens $490M breast cancer collab
Fierce Biotech · 27 days ago